FDA Management Changes Make Galson Permanent CDER Director
This article was originally published in The Tan Sheet
Stephen Galson, MD, will serve as Director of FDA's Center for Drug Evaluation & Research on a permanent basis, the agency announced July 29
You may also be interested in...
The confirmation of Lester Crawford as FDA Commissioner gives him three and a half years to cement his leadership, which has been under fire during his service as acting commissioner
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning